Abstract
The prevalence of allergic diseases has risen worldwide, especially among children and adolescents.1,2 Great efforts have been dedicated to identifying factors associated with allergic disease,3 and data have suggested associations between allergic diseases and acid-suppressive medication (ASM) use in fetal and early life.4-8 Meanwhile, ASMs, including proton pump inhibitors (PPIs) and histamine 2 receptor antagonists (H2RAs), are frequently used during pregnancy to treat gastroesophageal reflux disease (GERD),9 and in recent decades, the use of ASMs has substantially increased in both pregnant and pediatric populations.10,11

This publication has 62 references indexed in Scilit: